Caspases Are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis
暂无分享,去创建一个
S. Yonehara | T. Okazaki | H. Sawai | M. Sasada | A. Takahashi | H. Hirata | Kokichi Yamamoto | Susumu Kobayashi
[1] E. Nishida,et al. Fas Induces Cytoplasmic Apoptotic Responses and Activation of the MKK7-JNK/SAPK and MKK6-p38 Pathways Independent of CPP32-like Proteases , 1997, The Journal of cell biology.
[2] M. Su,et al. High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. , 1997, Cancer research.
[3] G M Cohen,et al. Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.
[4] N. Thornberry,et al. Caspases: killer proteases. , 1997, Trends in biochemical sciences.
[5] Y. Tsujimoto,et al. Caspase-4 and caspase-5, members of the ICE/CED-3 family of cysteine proteases, are CrmA-inhibitable proteases , 1997, Cell Death and Differentiation.
[6] N. Thornberry,et al. A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.
[7] F Gambale,et al. Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.
[8] P. Sims,et al. Molecular Cloning of Human Plasma Membrane Phospholipid Scramblase , 1997, The Journal of Biological Chemistry.
[9] Y. Tsujimoto,et al. Involvement of caspase-4(-like) protease in Fas-mediated apoptotic pathway , 1997, Oncogene.
[10] G. Kroemer,et al. The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis , 1997, The Journal of experimental medicine.
[11] G.T. Williams,et al. Caspase activity is required for commitment to Fas‐mediated apoptosis , 1997, The EMBO journal.
[12] P. W. Mesner,et al. Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8 , 1997, Oncogene.
[13] G M Bokoch,et al. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. , 1997, Science.
[14] K. Weber,et al. Cleavage of the nuclear matrix protein NuMA during apoptosis. , 1997, Experimental cell research.
[15] Eric A. Hendrickson,et al. A Sequential Two-Step Mechanism for the Production of the Mature p17:p12 Form of Caspase-3 in Vitro * , 1997, The Journal of Biological Chemistry.
[16] Matthias Mann,et al. FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC) , 1997, The EMBO journal.
[17] Yuri Lazebnik,et al. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells , 1997, The EMBO journal.
[18] H. Karasuyama,et al. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. , 1997, Experimental cell research.
[19] E. Reinherz,et al. T‐cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection , 1997, The EMBO journal.
[20] E. Alnemri,et al. Processing/Activation of At Least Four Interleukin-1β Converting Enzyme–like Proteases Occurs during the Execution Phase of Apoptosis in Human Monocytic Tumor Cells , 1997, The Journal of cell biology.
[21] Xiaodong Wang,et al. DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.
[22] C. Thompson,et al. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Gascoyne,et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. , 1997, Cancer research.
[24] J. Mankovich,et al. Substrate Specificities of Caspase Family Proteases* , 1997, The Journal of Biological Chemistry.
[25] G. Salvesen,et al. Target Protease Specificity of the Viral Serpin CrmA , 1997, The Journal of Biological Chemistry.
[26] W. Earnshaw,et al. Activation of Multiple Interleukin-1β Converting Enzyme Homologues in Cytosol and Nuclei of HL-60 Cells during Etoposide-induced Apoptosis* , 1997, The Journal of Biological Chemistry.
[27] E. Alnemri,et al. Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxide. , 1997, Experimental cell research.
[28] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[29] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.
[30] A. Chinnaiyan,et al. Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death , 1997, Science.
[31] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[32] G. Salvesen,et al. FLICE Induced Apoptosis in a Cell-free System , 1997, The Journal of Biological Chemistry.
[33] Emad S. Alnemri,et al. Activation of a CrmA-insensitive, p35-sensitive Pathway in Ionizing Radiation-induced Apoptosis* , 1997, The Journal of Biological Chemistry.
[34] W. Earnshaw,et al. CrmA/SPI-2 Inhibition of an Endogenous ICE-related Protease Responsible for Lamin A Cleavage and Apoptotic Nuclear Fragmentation* , 1996, The Journal of Biological Chemistry.
[35] J. Xiang,et al. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Srinivasula,et al. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Ratnofsky,et al. Proteolytic Activation of Protein Kinase C δ by an ICE/CED 3-like Protease Induces Characteristics of Apoptosis , 1996, The Journal of experimental medicine.
[38] Keisuke Kuida,et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.
[39] Seamus J. Martin,et al. Phosphatidylserine Externalization during CD95-induced Apoptosis of Cells and Cytoplasts Requires ICE/CED-3 Protease Activity* , 1996, The Journal of Biological Chemistry.
[40] S. Srinivasula,et al. The Ced-3/Interleukin 1β Converting Enzyme-like Homolog Mch6 and the Lamin-cleaving Enzyme Mch2α Are Substrates for the Apoptotic Mediator CPP32* , 1996, The Journal of Biological Chemistry.
[41] R. Flavell,et al. Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen Receptor , 1996, Cell.
[42] Junying Yuan,et al. Human ICE/CED-3 Protease Nomenclature , 1996, Cell.
[43] G. Kroemer,et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.
[44] G. Salvesen,et al. Molecular Ordering of Apoptotic Mammalian CED-3/ICE-like Proteases* , 1996, The Journal of Biological Chemistry.
[45] Y. Lazebnik,et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] D. Green,et al. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)- mediated T cell apoptosis , 1996, The Journal of experimental medicine.
[47] D. K. Miller,et al. Sequential activation of three distinct ICE‐like activities in Fas‐ligated Jurkat cells , 1996, FEBS letters.
[48] S. Srinivasula,et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[49] N. Thornberry,et al. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis , 1996, Nature Structural Biology.
[50] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[51] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.
[52] X. Liu,et al. Purification and Characterization of an Interleukin-1β-converting Enzyme Family Protease That Activates Cysteine Protease P32 (CPP32)* , 1996, The Journal of Biological Chemistry.
[53] M. Brown,et al. Purification and cDNA cloning of a second apoptosis-related cysteine protease that cleaves and activates sterol regulatory element binding proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[54] S. Nagata,et al. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.
[55] G. Cohen,et al. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. , 1996, The Biochemical journal.
[56] A. Abbas,et al. Die and Let Live: Eliminating Dangerous Lymphocytes , 1996, Cell.
[57] A. Chinnaiyan,et al. Molecular Ordering of the Cell Death Pathway , 1996, The Journal of Biological Chemistry.
[58] A. Chinnaiyan,et al. ICE-LAP3, a Novel Mammalian Homologue of the Caenorhabditis elegans Cell Death Protein Ced-3 Is Activated during Fas- and Tumor Necrosis Factor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.
[59] E. Alnemri,et al. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. , 1995, Cancer research.
[60] P. Williamson,et al. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes , 1995, The Journal of experimental medicine.
[61] D. Green,et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.
[62] Guido Kroemer,et al. The biochemistry of programmed cell death , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[63] Y. Lazebnik,et al. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[64] Seamus J. Martin,et al. Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.
[65] S. Nagata,et al. The Fas death factor , 1995, Science.
[66] C. Thompson,et al. Apoptosis in the pathogenesis and treatment of disease , 1995, Science.
[67] P. Petit,et al. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[68] D. Fisher. Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.
[69] P. Griffin,et al. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones. , 1994, Biochemistry.
[70] A. Rosen,et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.
[71] Y. Lazebnik,et al. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis , 1993, The Journal of cell biology.
[72] V. Fadok,et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.
[73] M. Snyder,et al. NuMA: an unusually long coiled-coil related protein in the mammalian nucleus , 1992, The Journal of cell biology.
[74] S. Yonehara,et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.
[75] D. Harrison,et al. Apoptosis: an overview of the process and its relevance in disease. , 1997, Advances in pharmacology.
[76] W. Earnshaw,et al. In vitro systems for the study of apoptosis. , 1997, Advances in pharmacology.
[77] Y. Lazebnik,et al. Biochemical Dissection of Nuclear Events in Apoptosis , 1997 .
[78] W. Earnshaw,et al. Nuclear changes in apoptosis. , 1995, Current opinion in cell biology.